Brief: Verrica Pharmaceuticals Inc. Q2 Adjusted EPS USD -0.21
08/08/2023 12:37
Aug 8 (Reuters) - Verrica Pharmaceuticals Inc. Q2 basic EPS USD -0.24. * Q2 net income USD -10.99 million * Q2 income from operations USD -11.616 million * Q2 collaboration revenue USD 182 thousand * Q2 adjusted net income USD -9.4 million * Q2 adjusted EPS USD -0.21
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data